Contenção do paciente agitado no Departamento de Emergência

Nazarian DJ, Broder JS, Thiessen MEW, et al. Clinical Policy: Critical Issues in the Diagnosis and Management of the Adult Psychiatric Patient in the Emergency Department. Ann Emerg Med. 2017;69(4):480-498.

Coburn, V. & Mycyk, M. (2009). Physical and Chemical Restraints. Emergency Medicine Clinics of North America. 27, 655-667.

Rossi, J. Swan, M. & Isaacs, E. (2010). The Violent or Agitation Patient. Emergency Medicine Clinics North America. 28, 235-256.

New A, Tucci VT, Rios J. A Modern-Day Fight Club? The Stabilization and Management of Acutely Agitated Patients in the Emergency Department. Psychiatr Clin North Am. 2017 Sep;40(3):397-410.

Nice.org.uk. (2018). Violence and aggression: short-term management in mental health, health and community settings | Guidance and guidelines | NICE. [online] Available at: https://www.nice.org.uk/guidance/ng10.

Wilson MP, Pepper D, Currier GW, Holloman GH Jr, Feifel D. The psychopharmacology of agitation: consensus statement of the American Association for emergency psychiatry project Beta psychopharmacology workgroup. West J Emerg Med. 2012 Feb;13(1):26-34.

Swift, RH, Harrigan, EP, Cappelleri, JC, et al, Validation of the behavioural activity rating scale (BARS): a novel measure of activity in agitated patients. Journal of Psychiatric Research, 2002. 36: p. 87‐95.

Zeller SL, Citrome L. Managing Agitation Associated with Schizophrenia and Bipolar Disorder in the Emergency Setting. West J Emerg Med. 2016;17(2):165-72.

Richmond JS, Berlin JS, Fishkind AB, et al. Verbal De-escalation of the Agitated Patient: Consensus Statement of the American Association for Emergency Psychiatry Project BETA De-escalation Workgroup. West J Emerg Med. 2012 Feb;13(1):17-25.

Glezer A, Brendel RW. Beyond emergencies: the use of physical restraints in medical and psychiatric settings. Harv Rev Psychiatry. 2010 Nov-Dec;18(6):353-8.

Downey LV, Zun LS, Gonzales SJ, Frequency of alternative to restraints and seclusion and uses of agitation reduction techniques in the emergency department. Gen Hosp Psychiatry, 2007. 29(6): p. 470‐4.

Martin B, Restraint use in acute and critical care settings: changing practice. AACN Clin Issues, 2002. 13(2): p. 294‐306.

Centers for Medicare and Medicaid Services. State Operations Manual. Department of Health and Human Services; 2008. Available at: https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/downloads/R37SOMA.pdf.

Zun LS. A prospective study of the complication rate of use of patient restraint in the emergency department. J Emerg Med. 2003 Feb. 24(2):119-24.

Coburn VA, Mycyk MB. Physical and chemical restraints. Emerg Med Clin North Am. 2009 Nov. 27(4):655-67, ix.

Zun LS. A prospective study of the complication rate of use of patient restraint in the emergency department. J Emerg Med. 2003 Feb. 24(2):119-24.

Annas GJ. The last resort–the use of physical restraints in medical emergencies. N Engl J Med. 1999 Oct 28. 341(18):1408-12.

Currier GW, Simpson GM, Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation. J Clin Psychiatry, 2001. 62(3): p. 153‐7.

Currier GW, Chou JC, Feifel D, Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam. J Clin Psychiatry, 2004. 65(3): p. 386‐94.

Nobay F, Simon BC, Levitt MA, Dresden GM. A prospective, double-blind, randomized trial of midazolam versus haloperidol versus lorazepam in the chemical restraint of violent and severely agitated patients. Acad Emerg Med. 2004;11(7):744-9.

Richards JR, Derlet RW, Duncan DR, Chemical restraint for the agitated patient in the emergency department: lorazepam versus droperidol. J Emerg Med, 1998. 16(4): p. 567‐73.

Martel M, Sterzinger A, Miner J, et al, Management of acute undifferentiated agitation in the emergency department: a randomized double‐blind trial of droperidol, ziprasidone, and midazolam. Acad Emerg Med, 2005. 12(12): p. 1167‐72.

Isenberg DL, Jacobs D. Prehospital Agitation and Sedation Trial (PhAST): A Randomized Control Trial of Intramuscular Haloperidol versus Intramuscular Midazolam for the Sedation of the Agitated or Violent Patient in the Prehospital Environment. Prehosp Disaster Med. 2015 Oct;30(5):491-5.

Kroczak S et al. Chemical Agents for the Sedation of Agitated Patient in the ED: A Systematic Review. Am J Emerg Med. 2016. (34); 2426-2431.

Gottlieb M, Long B, Koyfman A. Approach to the Agitated Emergency Department Patient. J Emerg Med. 2018;54(4):447-457.

Zun LS. Evidence-Based Review of Pharmacotherapy for Acute Agitation. Part 1: Onset of Efficacy. J Emerg Med. 2018;54(3):364-374.

Gottlieb M, Schiebout J. What Is the Efficacy of Droperidol for the Management of Acute Psychosis-Induced Agitation?. Ann Emerg Med. 2018;71(1):141-143.

Battaglia J, Moss S, Rush J, et al. Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study. Am J Emerg Med. 1997 Jul;15(4):335-40.

Bieniek SA, Ownby RL, Penalver A, Dominguez RA. A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation. 1998 Jan-Feb;18(1):57-62.

Hui D, Frisbee-Hume S, Wilson A, et al. Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial. 2017 Sep 19;318(11):1047-1056.

Le Cong M, Humble I. A Ketamine Protocol and Intubation Rates for Psychiatric Air Medical Retrieval. Air Med J. 2015 Nov-Dec;34(6):357-9.

Cole JB, Moore JC, Nystrom PC, et al. A prospective study of ketamine versus haloperidol for severe prehospital agitation. Clin Toxicol (Phila). 2016 Aug;54(7):556-62.

Riddell J, Tran A, Bengiamin R, Hendey GW, Armenian P. Ketamine as a first-line treatment for severely agitated emergency department patients. Am J Emerg Med. 2017 Jul;35(7):1000-1004.

Isbister GK, Calver LA, Downes MA, Page CB. Ketamine as Rescue Treatment for Difficult-to-Sedate Severe Acute Behavioral Disturbance in the Emergency Department. Ann Emerg Med. 2016;67(5):581-587.e1.

Vrana B. Use of Intranasal Ketamine for the Severely Agitated or Violent ED Patient. J Emerg Nurs. 2016;42(3):198-9.

Lahti AC, Koffel B, LaPorte D, Tamminga CA. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. 1995 Aug;13(1):9-19.

Peisah C, Chan DK, McKay R, Kurrle SE, Reutens SG. Practical guidelines for the acute emergency sedation of the severely agitated older patient. Intern Med J. 2011 Sep;41(9):651-7.

Aftab A, Shah AA. Behavioral Emergencies: Special Considerations in the Geriatric Psychiatric Patient. Psychiatr Clin North Am. 2017 Sep;40(3):449-462.

Kruse WH. Problems and pitfalls in the use of benzodiazepines in the elderly. Drug Saf. 1990 Sep-Oct;5(5):328-44.

Bogunovic OJ, Greenfield SF. Practical geriatrics: Use of benzodiazepines among elderly patients. Psychiatr Serv. 2004 Mar;55(3):233-5.